Search Results - "Prince, Peter J."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Prediction of clinical pharmacokinetics of AMG 181, a human anti‐α4β7 monoclonal antibody for treating inflammatory bowel diseases by Li, Hong, Köck, Kathleen, Wisler, John A., Rees, William A., Prince, Peter J., Reynhardt, Kai O., Hsu, Hailing, Yu, Zhigang, Borie, Dominic C., Salinger, David H., Pan, Wei‐Jian

    Published in Pharmacology research & perspectives (01-02-2015)
    “…The purpose of this study was to predict a safe starting dose of AMG 181, a human anti‐α4β7 antibody for treating inflammatory bowel diseases, based on…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Measurement of in vivo therapeutic mAb concentrations: comparison of conventional serum/plasma collection and analysis to dried blood spot sampling by Matsuda, Katherine C, Hall, Colin, Baker-Lee, Cassandra, Soto, Marcus, Scott, George, Prince, Peter J, Retter, Marc W

    Published in Bioanalysis (01-08-2013)
    “…Development of an alternative sampling method that uses small amounts of whole blood, such as dried blood spots (DBS), would be an advance in the quantitative…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Assessment of DBS technology for the detection of therapeutic antibodies by Prince, Peter J, Matsuda, Katherine C, Retter, Mw, Scott, G

    Published in Bioanalysis (01-08-2010)
    “…Quantitating levels of therapeutic proteins in serum or plasma is critical for determining exposure levels and establishing pharmacokinetic parameters…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Prediction of clinical pharmacokinetics of AMG 181, a human anti-α 4 β 7 monoclonal antibody for treating inflammatory bowel diseases by Li, Hong, Köck, Kathleen, Wisler, John A, Rees, William A, Prince, Peter J, Reynhardt, Kai O, Hsu, Hailing, Yu, Zhigang, Borie, Dominic C, Salinger, David H, Pan, Wei-Jian

    Published in Pharmacology research & perspectives (01-02-2015)
    “…The purpose of this study was to predict a safe starting dose of AMG 181, a human anti-α 4 β 7 antibody for treating inflammatory bowel diseases, based on…”
    Get full text
    Journal Article
  10. 10